Study of Kylo-11 for heart disease with high Lp(a)
Part of Heart & circulation, Hormones & metabolism clinical trials.
This trial tests a new drug, Kylo-11, for people with heart or blood vessel disease and high Lp(a), a type of cholesterol that raises risk of heart problems. The study will see if Kylo-11 can help lower that risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have a diagnosis of atherosclerotic cardiovascular disease (a buildup of plaque in your arteries) and high levels of Lp(a) in your blood.
- You do not have moderate to severe heart failure or a very weak heart pump.
- Your blood pressure is well-controlled (under 160/100).
- You have not had most types of cancer in the last 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an oral medicine (HRS-5346) to lower lipoprotein(a), a type of fat in the blood linked to heart problems. It might help people with high levels who are at increased risk for heart attacks or strokes.
This trial tests a new drug called AZD4954 for safety. It includes healthy volunteers and people with high Lp(a) or dyslipidemia. The goal is to see if the drug is safe and how the body processes it.
This study tests whether a new medicine called lepodisiran can shrink plaque in heart arteries for adults with high Lp(a) (a type of cholesterol linked to heart disease) who have had a heart event or are at serious risk. The trial uses CT scans to monitor changes in your arteries.
This trial tests a new medication (QLC7401) for people with high cholesterol that is not well controlled by their current treatment. It aims to see if the drug can help lower LDL-C (bad cholesterol) levels and reduce the risk of heart problems.
This trial tests whether a new once-daily pill called SAL0137 can safely lower Lp(a), a type of cholesterol that raises heart attack and stroke risk. It's for adults with high Lp(a) and other heart risk factors, like prior heart problems or diabetes.
This trial tests an experimental drug, QLC7401, for people with high LDL cholesterol that hasn't lowered enough with current treatments. It aims to see if the drug can help reduce cholesterol levels in patients who are already on stable cholesterol medication.
Hear when a new Lipoprotein Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.